Sign In
Buy OSUR
$3.95
-0.0500 (-1.25%)
At Close: Jun 03, 2026
OraSure Technologies, Inc. Prices Underwritten Offering of Common Stock
03:15am, Wednesday, 03'rd Jun 2020
After the underwriting discount and estimated offering expenses, OraSure expects to receive net proceeds of approximately $82.48 million. In addition, OraSure has granted the underwriters a 30-day op
Global PoC Platform and Technology Market 2020 Key Players, Opportunities, Challenges, Trend and Forecast by 2026
04:55am, Tuesday, 02'nd Jun 2020
Jun 01, 2020 (CDN Newswire via Comtex) --
Global PoC Platform and Technology Market 2020 by Company, Regions, Type and Application, Forecast to 2026 equipped...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 1)
Adaptimmune Therapeutics PLC...
OraSure Technologies, Inc. Announces Proposed Public Offering of Common Stock
08:01pm, Monday, 01'st Jun 2020
J.P. Morgan Securities LLC, Citigroup Global Markets Inc. and Evercore Group L.L.C. are acting as joint book running managers of the offering and as representatives of the underwriters. UBS Investmen
OraSure Technologies Reports 8M Share Common Stock Offering
12:00am, Monday, 01'st Jun 2020OraSure Technologies, Inc. Announces Purchase of UrSure, Inc.
11:00am, Friday, 29'th May 2020
OraSure Technologies, Inc. (OSUR), a leader in point of care diagnostic tests and specimen collection and stabilization devices, and microbiome laboratory and analytical services, today announced tha
OraSure Technologies Appoints Lelio Marmora to Board of Directors
10:00am, Friday, 29'th May 2020
OraSure Technologies, Inc. (OSUR), a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced the appointment of Lelio
OraSure Reports Purchase Of UrSure For $3M In Upfront Cash
12:00am, Friday, 29'th May 2020OraSure Technologies to Present at the Jefferies 2020 Healthcare Conference
10:00am, Tuesday, 26'th May 2020
BETHLEHEM, Pa., May 26, 2020 -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory.
OraSure’s OMNIgene®·ORAL Kit Included in EUA Granted to P23 Labs for At-Home Collection of Saliva Samples for SARS-CoV-2 Test
11:00am, Friday, 22'nd May 2020
OTTAWA, May 22, 2020 -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and.
Diversigen Inc. Selected by Nom Nom™ as the Preferred Provider for Metagenomics and Microbiome Sequencing and Analysis Services
10:00am, Friday, 22'nd May 2020
Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (OSUR), and Nom Nom™, a direct-to-consumer pet health brand, today announced that Nom Nom has selected Diversigen as their preferred provi
